| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |